ampelopsin has been researched along with Invasiveness, Neoplasm in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Li, B; Liu, C; Wang, L; Xu, X; Yang, Y; Zhao, P | 1 |
| Liu, DY; Zheng, HQ | 1 |
| Liu, DY; Luo, GQ; Zheng, HQ | 1 |
| Ho, YT; Hsin, CH; Huang, CC; Lin, CW; Lu, YT; Su, CW; Wang, PH; Yang, SF | 1 |
| Chen, XB; DU, JL; Wang, FJ; Wang, WS; Yuan, DP; Zong, XY | 1 |
| Chou, CH; Hsieh, YH; Lin, CW; Lu, KH; Yang, JS; Yang, SF | 1 |
| Li, MY; Li, R; Liu, B; Liu, J; Liu, ZK; Miao, HL; Qiu, ZD; Shu, Y; Wang, DJ; Zeng, GF; Zhang, QY; Zhu, RZ | 1 |
7 other study(ies) available for ampelopsin and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Ampelopsin suppresses TNF-α-induced migration and invasion of U2OS osteosarcoma cells.
Topics: Antineoplastic Agents, Phytogenic; Bone and Bones; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Flavonoids; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Osteosarcoma; p38 Mitogen-Activated Protein Kinases; Tumor Necrosis Factor-alpha | 2016 |
[Anti-invasive and anti-metastatic effect of ampelopsin on melanoma].
Topics: Animals; Antineoplastic Agents; Cell Movement; Disease Models, Animal; Flavonoids; Humans; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2003 |
[Effects of ampelopsin on invasion and metastasis of B16 mouse melanoma in vivo and in vitro].
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Adhesion; Cell Line, Tumor; Cell Movement; Flavonoids; Lauraceae; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Plants, Medicinal; Xenograft Model Antitumor Assays | 2003 |
Dihydromyricetin inhibits cancer cell migration and matrix metalloproteinases-2 expression in human nasopharyngeal carcinoma through extracellular signal-regulated kinase signaling pathway.
Topics: Cell Line, Tumor; Cell Movement; Extracellular Signal-Regulated MAP Kinases; Flavonols; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Signal Transduction | 2022 |
[Effects of dihydromyricetin on the migration and invasion of human gastric cancer MKN45 cells and its mechanism].
Topics: Cadherins; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Flavonols; Gene Expression Regulation; Humans; Neoplasm Invasiveness; Stomach Neoplasms; Vimentin | 2019 |
Dihydromyricetin suppresses cell metastasis in human osteosarcoma through SP-1- and NF-κB-modulated urokinase plasminogen activator inhibition.
Topics: Bone Neoplasms; Cell Line, Tumor; Cell Movement; Flavonols; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Osteosarcoma; Sp1 Transcription Factor; Urokinase-Type Plasminogen Activator | 2021 |
Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Hepatocellular; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Flavonols; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Phosphorylation; Protein Kinase C-delta; Signal Transduction; Time Factors | 2014 |